Cargando…

Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome

BACKGROUND: LL-37 is the only member of the cathelicidin family of antimicrobial peptides in humans and is an autoantigen in several autoimmune diseases and in acute coronary syndrome (ACS). In this report, we profiled the specific T cell response to the autoimmune self-antigen LL-37 and investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chernomordik, Fernando, Cercek, Bojan, Zhou, Jianchang, Zhao, Xiaoning, Lio, Nicole Wai Man, Chyu, Kuang-Yuh, Shah, Prediman K., Dimayuga, Paul C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083408/ https://www.ncbi.nlm.nih.gov/pubmed/37051254 http://dx.doi.org/10.3389/fimmu.2023.1113904

Ejemplares similares

The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification
por: Chernomordik, Fernando, et al.
Publicado: (2020)

Reduced Neointima Formation After Arterial Injury in CD4−/− Mice Is Mediated by CD8(+)CD28(hi) T Cells
por: Dimayuga, Paul C., et al.
Publicado: (2013)

The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice
por: Mihailovic, Peter M., et al.
Publicado: (2017)

IL-7R blockade reduces post-myocardial infarction-induced atherosclerotic plaque inflammation in ApoE(−/-) mice
por: Mihailovic, Peter M., et al.
Publicado: (2019)

Identification of apoB‐100 Peptide‐Specific CD8+ T Cells in Atherosclerosis
por: Dimayuga, Paul C., et al.
Publicado: (2017)

Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro
por: Chyu, Kuang-Yuh, et al.
Publicado: (2014)

Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice
por: Honjo, Tomoyuki, et al.
Publicado: (2015)

Sex as a Determinant of Responses to a Coronary Artery Disease Self-Antigen Identified by Immune-Peptidomics
por: Lio, Wai Man, et al.
Publicado: (2020)

Immunization using ApoB-100 peptide–linked nanoparticles reduces atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

Enhanced Neointima Formation Following Arterial Injury in Immune Deficient Rag-1−/− Mice Is Attenuated by Adoptive Transfer of CD8(+) T cells
por: Dimayuga, Paul C., et al.
Publicado: (2011)

Keratin 8 is a potential self-antigen in the coronary artery disease immunopeptidome: A translational approach
por: Mihailovic, Peter M., et al.
Publicado: (2019)

CD8(+) T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide
por: Chyu, Kuang-Yuh, et al.
Publicado: (2012)

Electrocardiograms in Critical Care Cardiology: Is it Acute Coronary Syndrome?
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
por: Chyu, Kuang-Yuh, et al.
Publicado: (2015)

Electrocardiograms in Critical Care Cardiology
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

ECGs in Critical Care Cardiology: Do Not Miss That Myocardial Infarction
por: Chyu, Kuang-Yuh, et al.
Publicado: (2022)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Death, autoantigen modifications, and tolerance
por: Utz,, Paul J, et al.
Publicado: (2000)

Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma
por: Jiao, Delong, et al.
Publicado: (2017)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Serum LL‐37 and inflammatory cytokines levels in psoriasis
por: Lao, Juanfeng, et al.
Publicado: (2023)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils
por: Zhang, Zhifang, et al.
Publicado: (2019)

Role of LL-37 in thrombotic complications in patients with COVID-19
por: Duan, Zilei, et al.
Publicado: (2022)

Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer
por: Fan, Rangrang, et al.
Publicado: (2015)

The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013)

LL-37 at the local site of streptococcal skin and soft-tissue infections
por: Thulin, Pontus, et al.
Publicado: (2007)

Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo
por: Scott, Aaron, et al.
Publicado: (2011)

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis
por: Murakami, Masamoto, et al.
Publicado: (2014)

Serum Levels of LL-37 and Inflammatory Cytokines in Plaque and Guttate Psoriasis
por: Hwang, Young Ji, et al.
Publicado: (2014)

LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure
por: Sol, Asaf, et al.
Publicado: (2012)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7fpdmjqht22alpvsn46gvlhmlt